Publications Search - Abstract View

Title: Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.
Authors: Sampson JN,  Falk RT,  Schairer C,  Moore SC,  Fuhrman BJ,  Dallal CM,  Bauer DC,  Dorgan JF,  Shu XO,  Zheng W,  Brinton LA,  Gail MH,  Ziegler RG,  Xu X,  Hoover RN,  Gierach GL
Journal: Cancer Res
Date: 2017 Feb 15
Branches: BB, EBP, MEB, OD
PubMed ID: 28011624
PMC ID: PMC5313342
Abstract: Endogenous estradiol and estrone are linked causally to increased risks of breast cancer. In this study, we evaluated multiple competing hypotheses for how metabolism of these parent estrogens may influence risk. Prediagnostic concentrations of estradiol, estrone, and 13 metabolites were measured in 1,298 postmenopausal cases of breast cancer and 1,524 matched controls in four separate patient cohorts. The median time between sample collection and diagnosis was 4.4 to 12.7 years across the cohorts. Estrogen analytes were measured in serum or urine by liquid chromatography-tandem mass spectrometry. Total estrogen levels (summing all 15 estrogens/estrogen metabolites) were associated strongly and positively with breast cancer risk. Normalizing total estrogen levels, we also found that a relative increase in levels of 2-hydroxylation pathway metabolites, or in the ratio of 2-hydroxylation:16-hydroxylation pathway metabolites, were associated inversely with breast cancer risk. These associations varied by total estrogen levels, with the largest risk reductions occurring in women in the highest tertile. With appropriate validation, these findings suggest opportunities for breast cancer prevention by modifying individual estrogen metabolism profiles through either lifestyle alterations or chemopreventive strategies. Cancer Res; 77(4); 918-25. ©2017 AACR.